Utama › Neurofibroma Pleksiform › Maryland
Kajian klinikal Neurofibroma Pleksiform di Maryland
6 kajian untuk Neurofibroma Pleksiform sedang mencari peserta di lokasi di Maryland.
Teks kajian rasmi (Bahasa Inggeris)
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 120 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 3 hingga 35 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT02390752A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Johns Hopkins Hospital, Baltimore
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- National Institutes of Health Clinical Center, Bethesda
Mengambil peserta
Umur 1 hingga 120 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Johns Hopkins University, Baltimore
- National Cancer Institute/ National Institutes of Health, Bethesda
Mengambil pesertaFasa 2
Umur 1 hingga 8 · Semua jantina · Dikemas kini 29 Mei 2026 · NCT06188741Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.